Stanley J. Meresman - Sep 10, 2021 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Stanley J Meresman
Stock symbol
GH
Transactions as of
Sep 10, 2021
Transactions value $
-$611,023
Form type
4
Date filed
9/14/2021, 05:07 PM
Previous filing
Aug 30, 2021
Next filing
Oct 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $29.3K +4.93K +121.56% $5.94 8.99K Sep 10, 2021 Direct
transaction GH COMMON STOCK Sale -$395K -3.05K -33.94% $129.31 5.94K Sep 10, 2021 Direct F1, F2
transaction GH COMMON STOCK Sale -$141K -1.08K -18.21% $130.11 4.86K Sep 10, 2021 Direct F1, F3
transaction GH COMMON STOCK Sale -$105K -800 -16.46% $131.12 4.06K Sep 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Options Exercise $0 -4.93K -11.11% $0.00 39.5K Sep 10, 2021 COMMON STOCK 4.93K $5.94 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.85 to $129.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.86 to $130.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.